Recombinant protein therapy articles from across Nature Portfolio A recombinant protein therapy is produced through recombinant DNA technology, which involves inserting the DNA encoding the ...

Under a strategic collaboration between Wacker and Gearbox Biosciences, both the companies will work together to accelerate ...

For decades, large stretches of human DNA were dismissed as "junk" and considered to serve no real purpose. In a new study ...

A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks ...

Roughly 10,000 years ago, humans started shifting from being nomadic hunter-gatherers to building large agricultural ...

The remains of early 1,100 victims — 40% of those who died — are still unidentified. The attack killed 2,753 at the World Trade Center.

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.

Once dismissed as “junk” DNA, ancient viruses embedded in the human genome play a key role in early human development, research finds.

This article explores how automation, AI and genetic tools are transforming cell line development, streamlining cloning, improving productivity and enabling faster biologic drug production.

It turns out that some of our DNA — about 8% — are the remnants of ancient viruses that embedded themselves into our genetic code.